High levels (lM) of beta amyloid (Ab) oligomers are known to trigger neurotoxic effects, leading to synaptic impairment, behavioral deficits, and apoptotic cell death. The hydrophobic C-terminal domain of Ab, together with sequences critical for oligomer formation, is essential for this neurotoxicity. However, Ab at low levels (pM-nM) has been shown to function as a positive neuromodulator and this activity resides in the hydrophilic N-terminal domain of Ab. An N-terminal Ab fragment (1-15/16), found in cerebrospinal fluid, was also shown to be a highly active neuromodulator and to reverse Abinduced impairments of long-term potentiation. Here, we show the impact of this N-terminal Ab fragment and a shorter hexapeptide core sequence in the Ab fragment (Abcore: 10-15) to protect or reverse Ab-induced neuronal toxicity, fear memory deficits and apoptotic death. The neuroprotective effects of the N-terminal Ab fragment and Abcore on Abinduced changes in mitochondrial function, oxidative stress, and apoptotic neuronal death were demonstrated via mitochondrial membrane potential, live reactive oxygen species, DNA fragmentation and cell survival assays using a model neuroblastoma cell line (differentiated NG108-15) and mouse hippocampal neuron cultures. The protective action of the N-terminal Ab fragment and Abcore against spatial memory processing deficits in amyloid precursor protein/PSEN1 (5XFAD) mice was demonstrated in contextual fear conditioning. Stabilized derivatives of the N-terminal Abcore were also shown to be fully protective against Ab-triggered oxidative stress. Together, these findings indicate an endogenous neuroprotective role for the N-terminal Ab fragment, while active stabilized N-terminal Abcore derivatives offer the potential for therapeutic application.
of soluble Ab years prior to a diagnosis of AD (reviewed in Holtzman et al. 2011) . In contrast, the levels of Ab normally present in brain in the absence of AD, estimated to be in the picomolar (pM) range, have been found to enhance synaptic regulation (Dougherty et al. 2003; Puzzo et al. 2008; Khan et al. 2010) , synaptic plasticity (Kamenetz et al. 2003; Cirrito et al. 2008; Puzzo et al. 2011 ) and fear memory (Puzzo et al. 2008) . In addition, Ab is produced and released from the pre-synaptic terminal (Lazarov et al. 2002) in an activity-dependent manner (Cirrito et al. 2008) and has a remarkably high turnover rate (Bateman et al. 2006) . Together, these findings suggest that Ab functions physiologically as a neuromodulator. As Ab accumulates to nanomolar (nM) levels or higher during the prodromal stages of AD, dysfunction of synaptic signaling and memory processing ensues (Selkoe 2002; Walsh et al. 2002) .
Ab is produced through the sequential enzymatic cleavage of the amyloid precursor protein (APP) via b-and c-secretases (Vassar et al. 1999) . As Ab is partially derived from the transmembrane (TM) domain of APP, the peptide has a C-terminal hydrophobic domain, which has been shown to largely but not exclusively account for its aggregation and neurotoxicity (cf. Haass and Selkoe 2007; Glabe 2008) . In contrast, a larger hydrophilic domain resides on the N-terminal side of the peptide. It has been shown that a 15-16 amino acid N-terminal Ab fragment (N-Ab fragment) can be produced from this hydrophilic domain via an a-secretase-linked pathway and is present at significant levels in cerebrospinal fluid (CSF) (Portelius et al. 2011) .
Previous work indicated that the Ab N-terminal domain is non-toxic (Whitson et al. 1989) . Through structure-function analysis, we have shown that Ab's neuromodulatory agonistlike activity toward nicotinic acetylcholine receptors (nAChRs) is contained within the hydrophilic N-terminal domain (Lawrence et al. 2014) . Moreover, we discovered that at pM-nM concentrations, the N-Ab fragment is approximately twice as effective as Ab in stimulating receptor-linked increases in Ca 2+ , enhancing long-term potentiation (LTP) and enhancing contextual fear conditioning (CFC) (Lawrence et al. 2014) . Moreover, treatment of hippocampal slices from transgenic mice expressing the Swedish mutation APP (hAPPswe: B6.SJL-Tg(APPswe:APP 695 K670N,M671L) 2576Kha) with the N-Ab fragment rescued LTP deficits shown to exist in this APP-AD mouse model (Lawrence et al. 2014) as the result of elevated Ab. We further narrowed down the core sequence accounting for the activity of the N-Ab fragment, identifying an essential and unique core hexapeptide sequence, YEVHHQ (N-Abcore). It was found to be as effective as the N-Ab fragment in eliciting Ca 2+ responses through nAChRs (Lawrence et al. 2014) .
To investigate the possible impact of the N-Ab fragment and N-Abcore on full-length Ab-induced neuronal toxicity in addition to Ab-induced behavioral deficits, model neuronal systems (neuroblastoma cell line NG108-15; isolated mouse hippocampal neurons) and a transgenic mouse model (5XFAD) were utilized to study responses, oxidative stress, apoptosis, and fear memory impairment, focusing on the neuroprotective potential of the N-Abcore, which offers a novel avenue for the development of AD therapeutics.
Materials and methods
Neuroblastoma clonal cell culture and transfection Rodent hybrid neuroblastoma NG108-15 cells (RRID:NCBITaxon_129386; courtesy of Dr William Atchison, Michigan State University) were used as a model nerve cell system allowing reconstitution with defined target receptors for Ab (Khan et al. 2010) . The cells were cultured in high-glucose Dulbecco's modified Eagle's medium containing 15% fetal bovine serum (FBS) and differentiated in the presence of reduced serum (1% FBS) and 1 mM dibutyryl cyclic AMP for 72 h (Tong et al. 2011; Arora et al. 2013) . Under these differentiation conditions, the cells extend axonal processes having pre-synaptic varicosities (identified morphologically and by pre-synaptic markers) capable of forming cholinergic synapses with the appropriate post-synaptic target (see Rond e and Nichols 2001). Expression vectors (pcDNA3.1) containing mouse sequences for a4 and b2 nAChR subunits (courtesy of Dr. Jerry Stitzel, University of Colorado) were transiently transfected into the cells at 1 : 4 ratio, respectively, using FuGENE HD (ThermoFisher, Carlsbad, CA, USA, catalog # PRE2311; RRID:SCR_008452) for 48 h. Mock-transfected NG108-15 cells, exposed only to FuGENE HD and not plasmid DNA, were used as controls (Tong et al. 2011) .
Hippocampal neuron culture
All animal procedures (handling; euthanasia) followed an Institutional Animal Care and Use Committee-approved protocol (Ethical approval reference: 16-2282), compliant with NIH and Society for Neuroscience guidelines for use of vertebrate animals in neuroscience research. The study was not pre-registered. Hippocampal neuron cultures were prepared as described (Cheng and Yakel 2015) from neonatal mouse pups (0-2 d old; one litter (6-10 mice)/ preparation from female mice housed in the John A. Burns School of Medicine AAALAC-accredited Vivarium) of either gender (roughly equivalent numbers) obtained from established colonies of wild-type B6.SJL (background; RRID:IMSR_JAX:100012) mice. Following rapid decapitation, brains were removed into icecold Neurobasal A medium (NB) containing B-27 supplement, 5% fetal bovine serum and Gentamicin (serum NB). Hippocampi were then isolated under a stereomicroscope. The hippocampi were digested with papain (Worthington, LS003126, Lot # 35N16202; RRID not registered) in Hanks buffer with 10 mM cysteine at 37°C for 15mins. The preparations were washed by centrifugation in serum NB. The cells were dissociated using sequential trituration with polished Pasteur pipettes of decreasing diameter and collected by low-speed centrifugation. The dissociated cells were pre-plated in standard tissue culture dishes to remove adherent non-neuronal cells (glia; fibroblasts) for 10-15 min. The neuron-enriched supernatant was diluted to 1 9 10 5 cells/mL and plated into poly-D-lysinecoated 24-well dishes or onto Cell Tak-coated coverslips in serum NB. The cultures were maintained in Neurobasal A medium containing B27 and Gentamicin for 7-10 days prior to treatment.
Confocal imaging of intracellular calcium
Changes in intracellular Ca 2+ levels in individual varicosities of differentiated NG108-15 cells were monitored by the Ca 2+ -selective fluorescent dye Fluo-4, as described (Khan et al. 2010) . Fluo-4/AM (Invitrogen, Carlsbad, CA, USA, catalog # F23917; RRID: SCR_008452) was loaded into the differentiated cells cultured on Cell-Tak-coated coverslips. Fluo-4-loaded cultures were perfused with oxygenated HEPES-buffered saline (HBS: 142 mM NaCl, 2.4 mM KCl, 1.2 mM K 2 PO 4 , 1 mM MgCl 2 , 1 mM CaCl 2 , 5 mM D-glucose, 10 mM HEPES (pH 7.4), 100 nM tetrodotoxin) via a rapid exchange Warner perfusion chamber. Changes in fluorescent intensity (F) in response to various treatments (Ab alone or in combination with N-Ab fragment or N-Abcore with pre-treatment, co-treatment or post-treatment; Ab or the N-Ab fragment followed by co-treatment with the N-Abcore) were visualized by a Nikon PCM 2000 Chameleon confocal imaging system. Each time-series was normalized to baseline fluorescence intensity at time zero (F 0 ) to yield the relative change in Ca 2+ i (as F/F 0 ). Peak responses for four to ten varicosities per sample were collected during 60-180 s after the initiation of stimulation and determined across all frames using ImageJ software (NIH, Bethesda, MD, USA).
Mitochondrial membrane potential
The mitochondrial membrane potential was measured using TMRE (tetramethyl rhodamine ethyl ester) -mitochondrial membrane potential assay kit (Invitrogen, catalog # T669; RRID: SCR_008452). Briefly, nAChR-transfected NG108-15 cells were treated over one to 5 days with either Ab or Abcore. The cells were incubated with 50 nM TMRE in HBS for 20 min and imaged live using an Olympus IX71 epifluorescence microscope at excitation/ emission of 549/575 nm, respectively.
Reactive oxygen species (ROS)/Hoechst staining Oxidative stress was determined by changes in the levels of ROS using the Image iT Live Reactive Oxygen Species (ROS) Detection kit (Invitrogen, catalog # I36007; RRID:SCR_008452) (Lipinski et al. 2010) . In brief, cells were subjected to various treatments for 3 days in the case of NG108-15 cultures and five or 10 days for primary hippocampal neuronal cultures. The medium for each treatment condition was changed every day, unless otherwise noted. At the end of the treatment periods, the cells were incubated with carboxy-H 2 DCFDA (component A) at 37°C for 30 min. During the last 5 min of incubation, 2 lg/ml of HOECHST stain (component B) was added to assess, in parallel, the integrity of the cell nuclei. The cells were washed twice with HBS and visualized using an Olympus IX71 or IX81 epifluorescence microscope at excitation/emission of 495/529 nm (ROS) and 350/461 nm (HOECHST), respectively.
Cell survival
Cell survival was determined by counting cells everyday for 7 or 10 days of treatment. For each treatment condition, all cells in 5 random fields of view were counted and averaged. The percent cell survival was calculated based on daily cell counts as a proportion of starting cell count numbers (i.e. Day 0): 100 9 average cells remaining each day/initial average cell number on Day 0.
Terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling (TUNEL) assay Apoptosis was measured using TUNEL staining via a Click-iT TUNEL Alexa Fluor488 Imaging Kit (Invitrogen, catalog # C10245; RRID:SCR_008452) in accordance with the manufacturer's protocol (see Arora et al. 2013) . In brief, the cells were subjected to various treatments for 4 days, exchanging the medium each day. After the fourth day of treatment, the cells were fixed with freshly prepared 4% paraformaldehyde (neutralized with NaOH while heating to produce formaldehyde) in phosphate-buffered saline (PBS) for 20 min and permeabilized with Triton X-100 (0.25% in PBS) for another 20 min. The cultures were then washed twice and incubated with 50 lL of terminal deoxynucleotidyl transferase reaction buffer (Component A) for 10 min. The buffer was replaced with TUNEL reaction mixture containing terminal deoxynucleotidyl transferase and incubated in a humidified chamber at 37°C for 60 min. The cells were then washed three times with 3% bovine serum albumin in PBS for 2 min each and thereafter, incubated with 50 lL of Click-iT reaction mixture (containing Alexa 488 azide) for 30 min at 23°C, protected from light exposure. The cells were again washed with 3% bovine serum albumin in PBS and the cell nuclei were counterstained with Hoechst 33342 for 15 min at 23°C, protected from light. The coverslips were washed twice with PBS before mounting onto a slide with Vectashield mounting medium (Vector Laboratories, catalog # H-1200; RRID: SCR_000821).
Computational modeling
Computational peptide docking of the N-Abcore into the Alpha7-nAChR-AChBP (binding protein) chimera (Li et al. 2011 ) was performed using GalaxyPepDock under GalaxyWEB (Lee et al. 2015) . For the Alpha7-nAChR-AChBP, the X-ray crystallographic structure encompassing two adjacent subunits containing the ligandbinding domain, equivalent in all five sites in the pentameric receptor, was used in an energy-optimization algorithm allowing undirected flexible target docking. Starting with peptide-protein interaction pair similarity scores obtained residue by residue, model building via GalaxyPepDock under GalaxyWEB was then performed using distance restraints for peptide-protein pairs, followed by GalaxyRefine to adjust backbone and side-chains through repetitive molecular dynamic relaxation. The docking models were then ranked by energy values. The top model based on the optimized energy score is presented. Single-trial contextual fear conditioning was then performed, entailing exposure of mice for 180 s to a context consisting of a separate fear conditioning box containing a plexiglass cage (36 9 21 9 20 cm), wherein the mouse explores the context, followed by a mild foot shock of 0.8 mA for 2 s delivered through a stainless steel grid floor. Contextual fear memory recall was tested after 24 h by measuring freezing response (absence of movement) when the mouse was placed back in the conditioning context. An additional remote memory test was performed wherein the mouse was re-introduced to the context 12 days after initial training and the extent of freezing response measured. Basic locomotion and shock were automatically measured through the computer-controlled fear conditioning TSE software (TSE Systems, Bad Homburg, Germany; RRID not registered). Freezing, which is defined as a lack of movement, was recorded every 10 s by an observer blinded to the treatment conditions for a total of 18 sampling intervals (180 s total). A minimum sample size of six per group was used for all NAb fragment experiments, or 3-4 per group for N-Abcore experiments, with the timing and dosage based on previous studies (Sherrin et al. 2010; Lawrence et al. 2014) . Data were graphed and analyzed using one-way ANOVA on Prism (GraphPad Prism v5.0b; RRID:SCR_002798). There is no evidence that the N-Abcore has an effect on Ab oligomer formation.) All peptides were synthesized and isolated at > 98% purity, as assessed by mass spectrometry. Ab (1-42), the N-Ab fragment (1-15), and the N-Abcore (10-15) and mutant forms were solubilized in double-distilled water and used at pM to nM final concentration in buffered saline (Tong et al. 2011) .
Contextual fear conditioning

Human Ab and derivatives
Reagents
All standard reagents (buffers, salts, tissue culture media and substrates, paraformaldehyde, Triton X-100, etc.) were obtained from Sigma (RRID:SCR_008988) or ThermoFisher (RRID: SCR_008452) and were of the highest grade available (> 98% purity). Plasmid purification maxiprep kits were from Qiagen, Valencia, CA, USA (catalog # 12262; RRID:SCR_008539) or Zymo Research, Irvine, CA, USA (catalog# D4202; RRID: SCR_008968). FBS was purchased from Omega Scientific, Tarzana, CA, USA (catalog # FB-11, Lot # 514205; RRID not registered). Neurobasal medium (catalog# 21103049) and B-27 supplement (catalog# 17504044) were from Invitrogen/ThermoFisher (RRID: SCR_008452). Dibutyryl cyclic AMP was purchased from Sigma (catalog # D0627; RRID:SCR_008988). Tetrodotoxin was purchased from Abcam, Cambridge, UK (catalog # ab120054, Lot # GR169765; RRID:SCR_012931). BD Cell-Tak was obtained from VWR (catalog # 47743-684, Lot # 7100009; RRID not registered).
Statistical analyses
Treatment and units were randomized as to order (under simple randomization protocols) for all assays and experiments. Biological replicates were based on independent samples (n). All experiments were repeated at least three times. No sample calculation was performed, as the sample size and replicates were based on previously published studies. All quantitative results are presented as boxplots (5-95% confidence intervals), where appropriate, or means AE SEM. Statistical analyses were performed using Prism (GraphPad v5.0b; RRID:SCR_002798), following checks for normality using the Komogorov-Smirov test. Multiple comparisons were made using one-way ANOVA with Bonferroni or Tukey post hoc tests, as indicated. Paired comparison were made using Student's t-tests. p-values < 0.05 were considered the minimum for significance (as rejection of the null hypothesis).
Results
N-Abcore and N-Ab fragment are highly effective, potent activators of a7-and a4b2-nAChRs We have previously shown that the N-Abcore (10-15) and N-Ab fragment (1-15) have similar potencies to that of Ab 1-42 as neuromodulators, measured as changes in presynaptic Ca 2+ in the axonal varicosities of a7-nAChRtransfected, differentiated neuroblastoma NG108-15 cells used as a reconstituted model neuronal system (Lawrence et al. 2014) . In order to determine the key functional residues in the core sequence, YEVHHQ, screening of numerous N-Abcore mutants was performed using Fluo-4 to measure relative changes in intracellular Ca 2+ . We found that mutating the His-13 and His-14 to Ala-13 and Ala-14 (H13A,H14A), respectively, reduced activity compared to the wild-type N-Abcore (p < 0.001), whereas mutating the Gln-15 to His-15 (Q15H) showed a trend toward an increase in activity (Fig. 1a ). An alanine scan across the remaining residues of the N-terminal of the N-Abcore resulted in no significant change in the a7-nAChR-linked Ca 2+ responses (Table S1 ). These findings suggest that His-13 and His-14 are critical in eliciting activity, which is consistent with previous mutational analysis of N-Ab fragments (Wang et al. 2000; Dougherty et al. 2003) as well as full-length Ab (Poduslo et al. 2010; Lawrence et al. 2014) .
To translate these findings into our neuronal toxicity model, we performed a similar set of experiments with a4b2-nAChR-transfected cells, which were previously shown to respond to Ab 1-42 in an a4-dependent manner (Arora et al. 2013) . Using the same approach, we demonstrated that the N-Abcore and the N-Ab fragment retain their neuromodulatory activity at nM ( Fig. 1b; Fig. S1 ) and pM (Fig. S2) concentrations. In accordance with our earlier findings, the H13A,H14A mutation reduced activity compared to the NAbcore (p < 0.05), whereas the Q15H mutation showed a trend toward an increase in activity (Fig. 1b) . In contrast, mutation of Glu-11 and Val-12 to Alanine showed no difference in activity (Table S1 ). However, a significant reduction was observed on mutating Tyr-10 to an Alanine when compared to the wild-type N-Abcore ( Fig. 1b ; p < 0.05 vs. wild-type). Mutation of Tyr-10 to a Serine also significantly reduced activity in both a7-and a4b2-nAChRtransfected cells (Table S1) , with a trend evident in the truncation mutants with removal of this tyrosine. This loss in activity suggests that the tyrosine residue also plays a role in the N-Abcore's activity toward a4b2-nAChRs, possibly through the aromatic and hydroxyl moieties (Tong et al. 2011) . We have previously shown that Tyr-188 in the ligand binding domain of a7 nAChR plays an essential role in the agonist action of Ab in pre-synaptic regulation (Tong et al. 2011) and thus ligand-target aromatic side chain interactions may be involved (see Fig. 3 ).
Prolonged treatment with the N-Abcore elicits a transient Ca 2+ response, whereas the N-Ab fragment induces a sustained but attenuated response compared to full-length Ab To mimic prolonged exposure of neurons to amyloid peptides, we measured the effects of Ab 1-42 , N-Abcore or N-Ab fragment on a4b2-nAChR-linked Ca 2+ responses in our neuronal model over an extended period of time. Treatment with 100 nM Ab 1-42 induced a long, sustained increase in Ca 2+ out to tens of minutes (Fig. 2a) , similar to previous findings (Khan et al. 2010) . The N-Ab fragment (100 nM) also elicited a sustained but significantly reduced response. In contrast, 100 nM N-Abcore induced only a transient spike in activity that peaked at 2 min of treatment, returning back to baseline after 4 min (Fig. 2a) . These findings suggest that the N-Abcore and N-Ab fragment differentially couple to target receptors to induce changes in internal Ca 2+ in comparison to the sustained changes on prolonged exposure to Ab 1-42 , which likely lead to dysregulation of mitochondria (Zempel et al. 2010; Arora et al. 2013) . The extent to which these differences in primary signaling account for the absence of toxicity for these N-Ab fragments remains to be determined. However, co-treatment with N-Abcore following prolonged application of Ab or the N-Ab fragment strongly attenuated the Ca 2+ responses (Fig. 2b) .
Docking of the N-Abcore into the Alpha7 nAChR-AChBP chimera using molecular modeling We sought to identify potential mechanisms by which the NAbcore interacts with nAChRs. To evaluate the potential interaction of the N-Abcore with known target Ab receptors, we employed computational peptide docking (GalaxyPepDock under GalaxyWEB (Lee et al. 2015) ) using the X-ray crystal structure of the Alpha7 nAChR-AChBP (binding protein) chimera (Li et al. 2011) . The nAChRs represent high-affinity receptors for Ab in functional studies (Wang et al. 2000; Dougherty et al. 2003; Chin et al. 2007; Puzzo et al. 2008; Tong et al. 2011 ) and hence were used as prototypic, representative but not exclusive targets for Ab. The peptide docking program, GalaxyPepDock, uses a flexible-structure (ligand and target), energy-based method independent of template or known interactions and displays high accuracy for binding site residues identified via separate approaches (e.g. mutational analysis). The docking process is automated and is not biased by user choice of binding sites or peptide conformations. The top model (out of 10) is shown in Fig. 3 . Interestingly, the N-Abcore (black) was docked in a conformation very similar to that solved for the N-Abcore sequence within the NMR solution structure of the N-Ab fragment (Zirah et al. 2006) , namely with the two His residues extending in opposite directions off a slightly curved overall structure. Moreover, GalaxyPepDock docked the NAbcore into the known ligand-activation binding pocket in the alpha7 nAChR formed between two subunits of the receptor and underneath the C-loop (Fig. 3a and b: light blue), which contains Y188 (Fig. 3c : blue arrow) shown to be critical for Ab-mediated activation of rodent alpha7 nAChR (Tong et al. 2011) . In the top model, Y10 of the NAbcore was oriented near the alpha7 C-loop Y188. Lower scoring GalaxyPepDock models varied in peptide orientation, including reversed orientations of the overall structure (Q15 toward the C-loop with Y10 away), but the orientations of the His residues remained largely the same. The docking of the overall structure is similar to the ligand-target structure from crystals of epibatidine with the Alpha7 nAChR-AChBP chimera (Li et al. 2011) or carbamylcholine with the AChBP (Celie et al. 2004) . The inactive [H13A,H14A] N-Abcore (black) was found to dock in a similar conformation (Fig. 3d) but into a more compact pocket akin to that seen in the crystal structure without ligand. This binding mode suggests the [H13A,H14A] N-Abcore binds less favorably to the ligand activation site than the active N-Abcore. That the [H13A,H14A] N-Abcore does not protect against Ab 1-42 -induced oxidative stress at nM concentration (Fig. 4) suggests that the inactive peptide likely has a very low binding affinity for the Ab target receptor(s). Moreover, the activity of the N-Abcore, while transient, may also contribute to its neuroprotective role.
The N-Abcore rescues mitochondrial dysregulation induced by prolonged Ab 1-42 exposure Mitochondrial damage and dysfunction in AD due to the dysregulation of Ca 2+ signaling has been widely reported Hirai et al. 2001; Lin and Beal 2006) . We have previous shown that prolonged exposure to Ab 1-42 in our toxicity model altered mitochondrial dynamics, transport and size (Arora et al. 2013) . Here, we examined the integrity of the mitochondrial membrane potential over 5 days of Ab 1-42 treatment using the cell-permeant mitochondrial membrane potential probe TMRE. Depolarization of the membrane potential, indicated by a decrease in TMRE fluorescence across the cell population, was evident after just 1 day of Ab 1-42 treatment (Fig. 4a) , consistent with previous findings indicating that mitochondrial dysfunction is one of the earliest events in Ab neurotoxicity (e.g. Arora et al. 2013) . Treatment for 2 days and longer showed a greater extent of inactivation of the membrane potential, indistinguishable from 2 days on (Fig. 4a) . Co-treatment with the N-Abcore (3-day timeframe) prevented the Ab 1-42 -triggered depolarization of the mitochondrial membrane potential (Fig. 4b ).
The N-Abcore and the N-Ab fragment protect against full-length Ab-induced oxidative stress We have previously shown that prolonged treatment with Ab 1-42 induces oxidative stress (ROS), nuclei disintegration and apoptotic cell death in our in vitro neuronal toxicity model (Arora et al. 2013) . To assess the potential neuroprotective effects of the non-toxic N-Abcore, N-Abcore mutants or N-Ab fragment against Ab 1-42 -induced toxicity, we assessed these indicators following administration of the Nterminal peptides under various conditions with daily treatment with 100 nM Ab 1-42 . As previously shown, the presence of a4b2-nAChRs sensitizes the neuroblastoma NG108-15 cells to the toxicity of Ab 1-42 at nM concentration (Arora et al. 2013) . Co-treatment with the N-Ab fragment at similar or higher concentrations was able to prevent Ab 1-42 -induced oxidative stress (Fig. 5A ). In contrast, co-treatment of a7-nAChR-transfected cells with the N-Ab fragment and Ab 1-42 did not significantly protect against elevated ROS levels (Fig. S3) . Priming (pre-treatment) with the N-Ab fragment also significantly reduced Ab 1-42 -induced ROS (Fig. 5a) . The rescue treatment, in which the N-Ab fragment was introduced into the culture 1 day after Ab 1-42 , also attenuated ROS to a significant extent (Fig. 5a ). In addition, treatment with a cell-permeant antioxidant, N-acetylcysteine (NAC), which has been shown to reduce oxidative stressinduced damage in other systems (e.g. Farr et al. 2003) , verified that the Ab 1-42 -induced oxidative changes were the result primarily of reactive oxygen species. Turning to the N-Abcore, co-treatment at nM concentrations or post-treatment (rescue) for 3-, 2-, or 1-day reduced Ab 1-42 -induced ROS back to baseline levels (Fig. 5b) , suggesting that the N-Abcore also protects against of Ab 1-42 -induced toxicity, including late stages of oxidative stress.
In mock-transfected cells (absent nAChRs), higher concentrations (lM) of Ab 1-42 are required to induce significant levels of ROS. Co-treatment with nM-lM concentrations N-Abcore or N-Ab fragment reduced this oxidative stress compared to Ab 1-42 alone (Fig. 5C ), demonstrating that the N-Abcore or N-Ab fragment can protect against Ab 1-42 -induced toxicity independently of a4b2-nAChRs. Other studies have demonstrated that Ab, at higher concentrations, was able to exert its effects independently of identified receptors in neuronal cells (e.g. Zempel et al. 2010) We further examined whether the inactive [H13A,H14A] and highly active [Q15H] N-Abcore mutants had any protective effect on elevated oxidative stress from Ab 1-42 . We found that co-treatment with nM concentrations of the active mutant reduced ROS compared to Ab 1-42 alone (p < 0.001), whereas the inactive mutant had no significant effect (Fig. 5d) at the concentration tested. These results substantiate the specificity of action of the N-Abcore in neuroprotection against Ab 1-42 -induced oxidative stress.
N-Abcore and N-Ab fragment protect against Ab 1-42 -induced oxidative stress in primary hippocampal neurons We repeated the experiments in primary hippocampal cultures to assess the protective action of N-Ab fragment or N-Abcore in a relevant primary neuronal model. Primary mouse hippocampal neuron cultures were either treated daily with 1 lM Ab 1-42 , N-Ab fragment or N-Ab core alone, or co-treated with Ab 1-42 and N-Ab fragment or N-Abcore for 5 days (Fig. 6a ) or 10 days (Fig. 6b) . As expected, treatment with 1 lM Ab 1-42 resulted in 40-50% ROS-positive cells at 5 days and close to 70% ROS-positive cells at 10 days across the cell population. Co-treatment of cultures with 1 lM Ab 1-42 and 1 lM N-Ab fragment or 1 lM N-Abcore reduced the levels of ROS down to untreated (baseline) levels when compared to daily treatment with Ab 1-42 alone (p < 0.0001), demonstrating that the N-terminal Ab peptides were also able to fully protect against Ab-induced oxidative stress in primary neurons.
By way of comparison to assess specificity of the Nterminal peptide actions, the potential impact of the NAbcore or N-Ab fragment on excitotoxicity induced by glutamate in the hippocampal neuron cultures was tested. Only the N-Ab fragment at lM concentration partially attenuated the glutamate-triggered oxidative stress (ROS) (Fig. S4) . These results suggest that the action of the N-Abcore or N-Ab fragment may be preferential for neurotoxicity triggered by Ab.
Prolonged exposure to N-Abcore or N-Ab fragment protects against Ab 1-42 -induced apoptosis In addition to inducing oxidative stress, we have previously shown that the presence of a4b2-nAChRs sensitizes differentiated neuroblastoma NG108-15 cells to Ab 1-42 -induced apoptosis (Arora et al. 2013) , while elevated Ab 1-42 triggers apoptosis in the absence of nAChRs. Therefore, we assessed whether N-Abcore or N-Ab fragment can protect against Ab 1-42 -induced apoptosis with or without the presence of a4b2-nAChRs. Co-treatment with nM concentrations of the N-Abcore in the presence a4b2-nAChRs on day 1, 2 or 3 following the start of daily Ab 1-42 treatment reduced apoptosis compared to Ab 1-42 alone (p < 0.0001), as measured by TUNEL staining for apoptotic cells (Fig. 7a) , suggesting that the N-Abcore can protect against late stages of Ab 1-42 -induced neuronal death. In addition, high concentrations of Ab 1-42 induced apoptosis in the absence of the sensitizing a4b2-nAChRs, and co-treatments with nM-lM concentrations N-Abcore or N-Ab fragment over 4 days also reduced DNA-fragmentation compared to Ab 1-42 alone (p < 0.0001 for 100 nM and 1 lM N-Abcore; p < 0.001 and p < 0.0001, 100 nM and 1 lM N-Ab fragment, respectively), with a trend of greater reduction at lM concentrations (Fig. 7b) . These results indicate that the N-Abcore or N-Ab fragment can also protect against Ab 1-42 -induced neuronal death independently of the a4b2-nAChRs.
N-Abcore and N-Ab fragment protect against Ab 1-42 -induced cell death In cell survival assays, the impact of co-treatments with NAb fragment or N-Abcore on Ab 1-42 -induced cell death was assessed for cultures of either differentiated NG108-15 cells or mouse hippocampal neurons over 7-or 10-days through cell counts. As expected, 7-day cell counts in NG108-15 cultures showed significant cell death in a4b2-nAChRtransfected cells treated with Ab 1-42 alone (Fig. 8a ). Cotreatment with 100 nM N-Abcore as well as the N-Ab fragment was able to fully protect against Ab 1-42 -induced cell death at 7 days compared to Ab 1-42 alone (p < 0.0001). Similarly, at high concentrations (1 lM) both N-Ab fragment and N-Abcore protected primary hippocampal neurons against Ab 1-42 -induced cell death over 10-day treatments compared to Ab 1-42 alone (p < 0.0001; Fig. 8b ).
N-Abcore and N-Ab fragment protect against Ab-linked deficits in contextual fear conditioning in 5XFAD mice Spatial memory processing deficits in APP expressing mice have been linked to elevated Ab oligomers (Ashe 2001; Kimura and Ohno 2009) . Utilizing the 5XFAD mouse line as an accelerated model for Ab pathology (Oakley et al. 2006) , we confirmed that adult 5XFAD mice display pronounced deficits in contextual fear conditioning as compared to control mice on the B6.SJL background (Fig. 9) . On bilateral injection of the N-Ab fragment or N-Abcore into the dorsal hippocampi of the mice just prior to single-trial CFC (see Lawrence et al. 2014) , the fear memory was effectively restored to that observed for the control mice, as compared to mice injected with vehicle (sterile saline) alone (Figs. 9 and 10 ). The specificity of the effect of the N-Ab fragments was previously determined in dose-response comparisons of the Ab peptides tested alone, wherein very low concentrations enhanced CFC, while higher concentrations did not (Lawrence et al. 2014) . It was shown that the different B6.SJL and 5XFAD mouse groups (pre-injection) displayed no differences in locomotion (Fig. 9b) , nor did the mice show differences in response to shock (not shown), demonstrating that the effect of the N-Ab peptides was the result of restored fear memory processing and not sensory or motor impairments.
To evaluate the durability of the restored fear memory in the 5XFAD following injection of the N-Ab fragment or NAbcore, a remote memory test was conducted 12 days after the initial test. The contextual fear memory was maintained in the Ab fragment-injected 5X FAD mice (Fig. 10) . Taken together, these results demonstrate a neuroprotective action of the N-Ab peptides in vivo.
Stabilization of N-Abcore retains its receptor-linked Ca 2+ activity and protects against Ab 1-42 -induced neurotoxicity in a4b2-nAChR-transfected cells To protect the N-Abcore from exopeptidase degradation in vivo, we capped its N-terminus with an acetyl group and its C-terminus with an amide group. Relative to the N-Abcore, the capped-N-Abcore retained its potent activity (Fig. 11a) , with a trend towards an increased Ca 2+ response. To further protect the N-Abcore from endopeptidase activity, the enantiomeric conversion from the L-configuration to the D-configuration for each amino acid retained activity (Fig. 11a) , though the direct impact of enantiomeric conversion on interaction with the target remains to be determined In addition, the stabilized N-Abcore, at nM concentrations, was as neuroprotective against Ab 1-42 -induced oxidative stress as the N-Abcore ( Fig. 11c ; p < 0.05 vs. Ab 1-42 alone), indicating the potential for use of the stabilized peptide in vivo.
Discussion
A broad range of studies have shown that synaptic and behavioral dysregulation resulting from Ab is mainly due to soluble oligomeric forms of the peptide, while neuronal toxicity leading to neurodegeneration may be triggered by these same Ab oligomers but over an extended period of exposure (Haass and Selkoe 2007) . Structural analysis Fig. 9 Bilateral delivery of N-Ab fragment into the dorsal hippocampus restored fear memory in 5XFAD mice to normal wild-type levels. (a) Mice were treated and trained for contextual fear conditioning (CFC) using a single-trial paradigm with a mild foot shock 24 h before testing, as described in Materials and methods. 500 nM N-Ab fragment or sterile saline were bilaterally injected into the dorsal hippocampi 20mins before training. Freezing (% time immobile) was measured via TSE Systems videotracking software. Conditioned freezing was assessed by two trained observers. Data are means AE SEM, n = 5-6/group. *p < 0.05 comparing 5XFAD mice to wild-type B6.SFJ (background) mice; **p < 0.005 comparing 5XFAD mice injected with Ab 1-15 to saline (one-way ANOVA with Bonferroni post hoc tests). (b) General measure of locomotion for the B6.SJL and 5XFAD mice in (a) was assessed as the number of moves over 180s on the training day (day 1) for CFC (preinjection) via TSE videotracking software. n is the number of mice. Data are means AE SEM. (No significant differences) Fig. 10 Restoration of fear memory on bilateral delivery of N-Ab fragment or N-Abcore into the dorsal hippocampus in 5XFAD mice to normal WT levels maintained in remote memory. Upper: N-Ab fragment (Ab 1-15 ; n = 6-7/group). Lower: N-Abcore (Ab 10-15 ; n = 3-4/ group). contextual fear conditioning (CFC) (24 h) and Remote memory CFC (12 d). n is the number of mice. Data are means AE SEM; *p < 0.05, ***p < 0.001, two-tailed Student's t-test (Ab peptide vs. saline).
indicates that the hydrophobic C-terminal region of Ab, derived from the transmembrane region of APP, accounts for the toxicity of Ab due to the C-terminus looping back via a turn at residues 21-23 to form an anti-parallel beta-sheet (Morimoto et al. 2004) , with subsequent self-association Ab via the anti-parallel beta sheets to form the aforementioned soluble, low-and high-molecular weight oligomers (Walsh and Selkoe 2007) , not primarily the C-terminal sequence itself. While relatively high levels of Ab have been shown to induce selective toxicity, we hypothesized that the N-terminal domain has an independent function, based on our findings that Ab has a positive neuromodulatory role accounted for by the N-terminal domain (Lawrence et al. 2014) . To address this possibility, we examined the impact of peptide fragments derived from the N-terminal domain alone and in the context of Ab neurotoxicity. Our previous work showed that a non-toxic N-terminal fragment, found to arise endogenously from a-secretase activity in brain, was more effective than Ab in neuromodulation (Lawrence et al. 2014 ). In our current work, it was found that the N-terminal peptides (N-Abcore 10-15 and N-Ab fragment 1-15) induced differential responses to calcium signaling, particularly in comparison to full-length Ab which induces prolonged increases in intracellular calcium likely leading to mitochondrial dysregulation as well as changes in intracellular signaling pathways and gene expression. We further hypothesized that these non-toxic N-terminal Ab peptides would be neuroprotective against Ab 1-42 neurotoxicity, based on our previous findings demonstrating that the N-Ab fragment can reverse synaptic dysregulation resulting from full-length Ab (Lawrence et al. 2014) .
Previous evidence suggested that the neuromodulatory activity of N-Ab fragment, and hence Ab, resides in a core hexapeptide sequence, YEVHHQ, encompassing residues 10-15 in Ab. Through an alanine scan, we have found the two histidine residues at positions 13 and 14 to be of key importance in activating the a7-and a4b2-nAChRs, most likely due to their specificity to the target receptors, with significant contribution of the tyrosine at position 10. As previously noted, examining the N-Ab fragment and NAbcore over a prolonged time-frame also revealed qualitatively different Ca 2+ responses in the model neuronal system, with the N-Abcore triggering a relatively brief transient peak compared to the longer sustained Ca 2+ enhancement induced by Ab, consistent with previous findings (Dougherty et al. 2003; Khan et al. 2010) . In addition, studies have shown that Ab plays a role in disrupting Ca 2+ homeostasis by altering the activity of calcium conducting ion channels, including, notably, NMDA-type glutamate receptors (Wu et al. 1995; Ueda et al. 1997; Ferriera et al. 2012; Sinnen et al. 2016; ArbelOrnath et al. 2017) , and dramatically increasing IP 3 - mediated Ca 2+ release (Smith et al. 2001) . The variation in Ca 2+ responses may have been the result of differences in coupling to intracellular Ca 2+ , consequently activating different pathways and thus causing a unique signaling cascade for each N-terminal peptide. It may also be that the differences resulted in part from differences in nAChR inactivation; however, this would best be assessed through ionic current measurements. Nonetheless, the differential cellular responses to the N-Abcore and the N-Ab fragment may account for the lack of neurotoxicity by these peptides.
The underlying molecular mechanism(s) responsible for the prolonged increase in intracellular Ca 2+ caused by the neurotoxic actions of Ab may be a homeostatic failure. Considerable evidence supports a link between mitochondrial damage and dysfunction triggered by Ca 2+ dysregulation occurring early on in the disease. Changes in mitochondria function (Reddy 2007) , morphology (Baloyannis 2006; Arora et al. 2013) , and dynamics (Baloyannis 2006; Detmer and Chan 2007) resulting from the pathological effects of Ab have been reported, with changes in mitochondrial bioenergetics dependent on decoding Ca 2+ signals (Satr ustegui et al. 2007) . Here, we show that just 1 day of sustained Ab exposure was enough to affect the mitochondrial membrane potential in our model system. Ca 2+ homeostasis in the mitochondria is dependent upon the mitochondrial membrane potential, and, conversely, pathologically high levels of intramitochondrial Ca 2+ will collapse the membrane, resulting in an efflux of Ca 2+ triggering a celldeath signaling cascade (Giacomello et al. 2007 ). Interestingly, treatment with the N-Abcore prevents the inactivation of the membrane potential by Ab 1-42 , further suggesting that the transient Ca 2+ response elicited by the N-Abcore favors an alternative non-toxic pathway. Moreover, post-treatment with the N-Abcore attenuated the Ab 1-42 -triggered prolonged increase in intracellular calcium, further supporting its neuroprotective action against calcium dysregulation leading to mitochondrial dysfunction.
As we had previously shown that that the N-Ab fragment enhances synaptic regulation and fear memory, while reversing Ab-linked inhibition of LTP (Lawrence et al. 2014) , we subsequently addressed whether the N-Ab fragment and NAbcore were capable of protecting against Ab 1-42 -induced neuronal toxicity in two different cellular model systems in vitro as well as Ab-linked deficits in fear memory in vivo. Continuous co-treatment with the N-Ab fragment or NAbcore effectively and potently protected against Ab 1-42 -induced oxidative stress and apoptosis. Remarkably, treatment with the N-Ab fragment or N-Abcore after the induction of oxidative stress by Ab 1-42 also rescued the cells from this neurotoxicity. Furthermore, the fragment or N-Abcore were also protective against neurotoxicity induced by high concentrations of Ab 1-42 in the absence of sensitizing nAChRs (Arora et al. 2013) , again either with co-treatment or post-treatment rescue. In addition, only high levels (lM) of the N-Ab fragment protected against excitotoxicity in the primary neuron cultures. Together, these findings suggest that the NAb fragment and N-Abcore may be neuroprotective through altered binding of Ab 1-42 for key target sites and/or activation of alternative pathways, such as an anti-apoptotic pathway and/or anti-oxidative pathway, blocking or reversing the process by which Ab 1-42 induces neurotoxicity.
While the protective action of the N-Ab peptides against Abinduced cellular toxicity has ramifications for reduction in neurodegeneration over the long-term, the question of whether the N-Ab peptides have immediate impact on Ab-induced dysfunction of neuronal and synaptic signaling in vivo was addressed in contextual fear conditioning, a fully hippocampusbased memory paradigm for which APP/presenilin transgenic mice (5XFAD) display pronounced deficits. Indeed, bilateral injection of the N-Ab fragment or N-Abcore into the hippocampus just prior to single-trial CFC restored fear memory in the 5XFAD mice to that seen in the control mice, and the contextual fear memory trace was maintained for nearly 2 weeks in a remote memory test. The findings indicate a rapid reversal by the N-Ab peptides of the synaptic signaling dysfunction induced by prolonged elevated levels of Ab in the hippocampi of adult APP/presenilin (FAD) model mice. Which signaling systems and the mechanism by which the rapid reversal occurs remain to be explored, including, in particular, synaptic NMDA and a-amino-3-hydroxy-5-methylisoxazole-4-propionate glutamate receptors, which have shown to be altered in APP models (e.g. Snyder et al. 2005; Hsieh et al. 2006; Priller et al. 2009 ). In addition, confirmation of the effects of the N-Ab peptides using blood-brain barrier-penetrant derivatives via systemic administration in the APP/presenilin (FAD) mice will be an essential step in translating their neuroprotective action to therapeutic application.
Consistent with previous findings (Garcia-Rat es et al. 2016), we found the histidine residues in the N-terminal peptides to also be of essential importance in neuroprotection, indicating a necessary role in interaction with target Ab receptors. While the N-Abcore was found to dock into the ligand binding site of the nAChRs, it will be important to examine the nature of the interaction of the N-Abcore with other Ab target receptors, including, in particular, cellular prion and NMDA receptors. On the other hand, the rescue by the N-Abcore (and N-Ab fragment) long after initiation of the toxicity program by full-length Ab would strongly suggest that the neuroprotective action of these peptides in cellular toxicity, as well as synaptic and behavioral dysfunction, also includes altered intracellular signaling.
Conclusions
Currently, there is a wide array of intracellular and general acting agents, both natural and synthetic, that may protect against neuronal toxicity, synaptic inhibition or behavioral deficits to varying degrees, but our results suggest a highly effective endogenous, receptor-ligand-based, neuroprotective role for the N-Ab fragment at all levels. It will be of interest to investigate the circumstances and the degree to which the N-Ab fragment is generated at synaptic sites in brain, particularly as to whether the regulation of its production subserves neuromodulatory or neuroprotective roles. In regard to the N-Abcore, its neuroprotective potential in therapeutic application is bolstered by a fully stabilized version, which will increase its bioavailability and metabolic stability. Future studies will be directed toward further development of N-Abcore derivatives for utilization in Alzheimer's disease models. 
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